Pharmaceutical

Saama Technologies raises USD 40 Million to bolster AI Saama Technologies has got a hefty investment of USD 40million to accelerate its Artificial Intelligence and bolster its use in the branch of Life Sciences. This will help the California based data analytics company to innovate, curate and accelerate the clinical trials and deliver credible data. FDA approves the first-ever drug for PPD The U.S. FDA has approved the first-ever drug for treating postpartum depression (PPD). The drug Zulresso (brexanolone) will be injected intravenously (IV) and will be provided through a special program called the Zulresso REMS Program, which requires the drug to be admi...